A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors
Clinical trial NCT06238687 · COMPLETED
Trial details
- NCT number
- NCT06238687
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-08
- Primary completion
- 2025-06-06
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.